General
Preferred name
AZD5904
Synonyms
AZD-5904 ()
AZD 5904 ()
P&D ID
PD048621
CAS
618913-30-7
Tags
available
drug candidate
Drug indication
Chronic obstructive pulmonary disease
Multiple sclerosis
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION AZD5904 is compound TX4 in . AZD5904 was developed as a myeloperoxidase (MPO; P05164) inhibitor, but was abandoned as a clinical candidate for the treatment of inflammatory conditions involving oxidative stress. This compound is now included in AstaZeneca's Open Innovation Pharmacology Toolbox.
DESCRIPTION AZD5904 is a selective and irreversible inhibitor of human Myeloperoxidase (MPO) with an IC50 of 140 nM and has similar potency in mouse and rat.
PRICE 113
DESCRIPTION AZD5904 is compound TX4 in . AZD5904 was developed as a myeloperoxidase (MPO; P05164) inhibitor, but was abandoned as a clinical candidate for the treatment of inflammatory conditions involving oxidative stress. This compound is now included in AstaZeneca's Open Innovation Pharmacology Toolbox. (GtoPdb)
DESCRIPTION AZD-5904 is a potent orally bioavailable MPO inhibitor. It inhibited the isolated MPO enzyme with an IC50 value of 140 nM and was approximately equipotent in assays of rat and mouse MPO enzyme activity. It was used for multiple sclerosis and COPD and has been evaluated in single and multiple dose studies in healthy volunteers. (BOC Sciences Bioactive Compounds)
DESCRIPTION AZD5904 is a potent and irreversible inhibitor of human Myeloperoxidase (MPO, IC50: 140 nM) which has similar potency in mouse and rat. (TargetMol Bioactive Compound Library)
Compound Sets
10
BOC Sciences Bioactive Compounds
azd-5904-cas-618913-30-7-item-476047
Cayman Chemical Bioactives
33931
DrugMAP
DM8SCON
EU-OPENSCREEN Bioactive Compound Library
EOS101785
Guide to Pharmacology
7728
Mcule NIBR MoA Box Subset
MCULE-3293133474
MedChem Express Bioactive Compound Library
HY-111341
Novartis Chemogenetic Library (NIBR MoA Box)
ReFrame library
TargetMol Bioactive Compound Library
T14379
External IDs
20
Properties
(calculated by RDKit )
Molecular Weight
252.07
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
3
Aromatic Ring Count
2
cLogP
0.96
TPSA
75.7
Fraction CSP3
0.5
Chiral centers
1.0
Largest ring
6.0
QED
0.78
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Glutathione Peroxidase
MPO
Member status
member
MOA
Myeloperoxidase Inhibitors
Pathway
Apoptosis
Metabolic Enzyme/Protease
Metabolism
Solubility
Soluble in DMSO, not in water
Source data